| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Shuji Kanek. Motor vehicle collisions caused by the 'super-strength' synthetic cannabinoids, MAM-2201, 5F-PB-22, 5F-AB-PINACA, 5F-AMB and 5F-ADB in Japan experienced from 2012 to 2014. Forensic toxicology. vol 35. issue 2. 2020-10-01. PMID:28706566. |
these scs became available sequentially with increasing cannabinoid cb |
2020-10-01 |
2023-08-13 |
Not clear |
| Lucie Fojtíková, Anna Šuláková, Martina Blažková, Barbora Holubová, Martin Kuchař, Petra Mikšátková, Oldřich Lapčík, Ladislav Fuka. Lateral flow immunoassay and enzyme linked immunosorbent assay as effective immunomethods for the detection of synthetic cannabinoid JWH-200 based on the newly synthesized hapten. Toxicology reports. vol 5. 2020-10-01. PMID:29276691. |
in recent years, the use of synthetic cannabinoids (scs) as drugs of abuse has greatly increased. |
2020-10-01 |
2023-08-13 |
rabbit |
| Verena Angerer, Florian Franz, Bjoern Moosmann, Philippe Bisel, Volker Auwärte. 5F-Cumyl-PINACA in 'e-liquids' for electronic cigarettes: comprehensive characterization of a new type of synthetic cannabinoid in a trendy product including investigations on the in vitro and in vivo phase I metabolism of 5F-Cumyl-PINACA and its non-fluorinated analog Cumyl-PINACA. Forensic toxicology. vol 37. issue 1. 2020-10-01. PMID:30636986. |
a new trend is the use of e-liquids containing synthetic cannabinoids (scs) instead of smoking cannabis or herbal mixtures laced with scs. |
2020-10-01 |
2023-08-13 |
Not clear |
| Azita Alipour, Puja Baldev Patel, Zaheera Shabbir, Stephen Gabrielso. Review of the many faces of synthetic cannabinoid toxicities. The mental health clinician. vol 9. issue 2. 2020-10-01. PMID:30842917. |
synthetic cannabinoids (scs) are psychoactive substances that are gaining popularity for their availability and lack of detection by standardized drug tests. |
2020-10-01 |
2023-08-13 |
Not clear |
| Xingxing Diao, Marilyn A Huesti. New Synthetic Cannabinoids Metabolism and Strategies to Best Identify Optimal Marker Metabolites. Frontiers in chemistry. vol 7. 2020-10-01. PMID:30886845. |
synthetic cannabinoids (scs) were initially developed as pharmacological tools to probe the endocannabinoid system and as novel pharmacotherapies, but are now highly abused. |
2020-10-01 |
2023-08-13 |
Not clear |
| Osamah Hasan, Ankit A Patel, James J Sieger. A New Differential Diagnosis: Synthetic Cannabinoid-Associated Gross Hematuria. Case reports in medicine. vol 2019. 2020-10-01. PMID:30918521. |
recreational use of synthetic cannabinoids (scs), also known as "k2" or "spice," is becoming a major public-health concern due to their potential for abuse and harmful consequences. |
2020-10-01 |
2023-08-13 |
Not clear |
| b' \\xc3\\x87i\\xc4\\x9fdem \\xc3\\x87olak, Zehra \\xc3\\x87akmak \\xc3\\x87elik, Nabi Zorlu, \\xc3\\x96mer Kiti\\xc4\\xb1, Zeki Y\\xc3\\xbcnc\\xc3\\xb. Cortical Thickness and Subcortical Volumes in Adolescent Synthetic Cannabinoid Users with or Without ADHD: a Preliminary Study. Noro psikiyatri arsivi. vol 56. issue 3. 2020-10-01. PMID:31523140.' |
synthetic cannabinoids (scs) have become increasingly popular in the last few years, especially among adolescents. |
2020-10-01 |
2023-08-13 |
Not clear |
| Mitchell Longworth, Samuel D Banister, James B C Mack, Michelle Glass, Mark Connor, Michael Kassio. The 2-alkyl-2 Forensic toxicology. vol 34. 2020-09-30. PMID:27547266. |
the 2-alkyl-2 indazole-derived synthetic cannabinoids (scs) featuring an alkyl substituent at the 1-position and l-valinamide at the 3-carboxamide position (e.g., ab-chminaca) have been identified by forensic chemists around the world, and are associated with serious adverse health effects. |
2020-09-30 |
2023-08-13 |
Not clear |
| Kurt J Knowles, Eric X Wei, Abhishek Seth, John Bienvenu, James Morris, Kenneth Manas, Paul Jordan, Moheb Bokto. Synthetic Cannabinoid Abuse and a Rare Alpha-1-Antitrypsin Mutant Causing Acute Fulminant Hepatitis: A Case Report and Review of the Literature. Case reports in hepatology. vol 2017. 2020-09-30. PMID:29333304. |
synthetic cannabinoids (scs) abuse is on the rise because they are easily obtained over the counter; they are potent psychoactive compounds and routine drug testing does not detect them. |
2020-09-30 |
2023-08-13 |
Not clear |
| Katarzyna Ambroziak, Piotr Adamowic. Simple screening procedure for 72 synthetic cannabinoids in whole blood by liquid chromatography-tandem mass spectrometry. Forensic toxicology. vol 36. issue 2. 2020-09-30. PMID:29963203. |
in recent years, many synthetic cannabinoids (scs) have appeared on the drug market. |
2020-09-30 |
2023-08-13 |
Not clear |
| Hemant Goyal, Hamza H Awad, Jalal K Ghal. Role of cannabis in cardiovascular disorders. Journal of thoracic disease. vol 9. issue 7. 2020-09-29. PMID:28840009. |
synthetic cannabinoids (scs) are being increasingly investigated for their therapeutic effects; however, the value of their benefits over possible complications remains controversial. |
2020-09-29 |
2023-08-13 |
Not clear |
| David Hakimian, Orr Tomer, Nurith Hiller, Samuel N Heyman, Sarah Israe. Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature Review. Case reports in emergency medicine. vol 2017. 2020-09-29. PMID:29403666. |
worldwide use of synthetic cannabinoids (scs) is rapidly increasing, in part due to the generation of numerous new compounds, sidestepping legal restrictions. |
2020-09-29 |
2023-08-13 |
Not clear |
| Laith N Al-Eitan, Abdelqader S Asa'ad, AbdelKader H Battah, Hanan A Aljama. Application of Gas Chromatography-Mass Spectrometry for the Identification and Quantitation of Three Common Synthetic Cannabinoids in Seized Materials from the Jordanian Market. ACS omega. vol 5. issue 8. 2020-09-28. PMID:32149247. |
synthetic cannabinoids (scs) were developed to mimic the effects of Δ |
2020-09-28 |
2023-08-13 |
Not clear |
| Koby Cohen, Shiri Rosenzweig, Paola Rosca, Albert Pinhasov, Abraham Weizman, Aviv Weinstei. Personality Traits and Psychotic Proneness Among Chronic Synthetic Cannabinoid Users. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32477173. |
chronic use of synthetic cannabinoids (scs) has been associated with a wide range of negative consequences for health including psychotic and affective disturbances. |
2020-09-28 |
2023-08-13 |
Not clear |
| Koby Cohen, Yaniv Mama, Paola Rosca, Albert Pinhasov, Aviv Weinstei. Chronic Use of Synthetic Cannabinoids Is Associated With Impairment in Working Memory and Mental Flexibility. Frontiers in psychiatry. vol 11. 2020-09-28. PMID:32695029. |
we have recently shown that chronic use of synthetic cannabinoids (scs) has been associated with mood disorders and impairments in executive functions. |
2020-09-28 |
2023-08-13 |
Not clear |
| Cláudia C Miranda, Tiago Barata, Sandra H Vaz, Carla Ferreira, Alexandre Quintas, Evguenia P Bekma. hiPSC-Based Model of Prenatal Exposure to Cannabinoids: Effect on Neuronal Differentiation. Frontiers in molecular neuroscience. vol 13. 2020-09-28. PMID:32733202. |
synthetic cannabinoids (scs) are synthetic analogs of Δ |
2020-09-28 |
2023-08-13 |
Not clear |
| Rui Shen Ong, Diana C Kappatos, Sarah G G Russell, Helen A Poulsen, Samuel D Banister, Roy R Gerona, Michelle Glass, Cameron S Johnson, Mary-Jane McCarth. Simultaneous analysis of 29 synthetic cannabinoids and metabolites, amphetamines, and cannabinoids in human whole blood by liquid chromatography-tandem mass spectrometry - A New Zealand perspective of use in 2018. Drug testing and analysis. vol 12. issue 2. 2020-09-01. PMID:31595682. |
we describe the validation of a method for the simultaneous analysis of 29 synthetic cannabinoids (scs) and metabolites, 4 amphetamines, and 2 cannabinoids in human whole blood. |
2020-09-01 |
2023-08-13 |
human |
| Onur Karakayali, Uygar Utku, Serkan Yilmaz, Nevzat Uzune. Neurological Symptoms and Evaluation of Cerebral Blood Flow Changes with Synthetic Cannabinoids Use. Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. vol 29. issue 12. 2020-06-22. PMID:31839092. |
to describe the cerebral haemodynamic changes that occur in patients presenting to the emergency department (ed) after synthetic cannabinoid (sc) use in order to clarify the pathophysiology of neurologic adverse effects of scs. |
2020-06-22 |
2023-08-13 |
Not clear |
| Travon Cooman, Suzanne Bel. In vitro metabolism of the synthetic cannabinoids PX-1, PX-2, and PX-3 by high-resolution mass spectrometry and their clearance rates in human liver microsomes. Rapid communications in mass spectrometry : RCM. vol 33. issue 23. 2020-03-30. PMID:31364227. |
n-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1h-indole-3-carboxamine (px-1), n-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(5-fluoropentyl)-1h-indazole-3-carboxamide (px-2), and n-(1-amino-1-oxo-3-phenylpropan-2-yl)-1-(cyclohexylmethyl)-1h-indazole-3-carboxamide (px-3) are scheduled synthetic cannabinoids (scs). |
2020-03-30 |
2023-08-13 |
human |
| Anna-Maria Smolyakova, Ayat Zagzoog, Asher L Brandt, Tallan Black, Kawthar Mohamed, Robert B Laprairi. The Endocannabinoid System and Synthetic Cannabinoids in Preclinical Models of Seizure and Epilepsy. Journal of clinical neurophysiology : official publication of the American Electroencephalographic Society. vol 37. issue 1. 2020-03-18. PMID:31895186. |
cannabinoids can be divided into three broad categories: endogenous cannabinoids, plant-derived cannabinoids, and synthetic cannabinoids (scs). |
2020-03-18 |
2023-08-13 |
Not clear |